Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029055
Abstract: Abstract Introduction: Posttransplant lymphoproliferative disease (PTLD) is a critical complication of hematopoietic stem cell transplantation (HSCT). PTLD is classified into early and late-onset PTLDs. In post-HSCT patients, late-onset PTLD is rare, particularly PTLD after HSCT… read more here.
Keywords: ebv related; disease; ebv; epstein barr ... See more keywords
Successful Treatment of Central Nervous System Involvement in Posttransplant EBV-Related Lymphoproliferative Disease With Intrathecal Rituximab Therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002592
Abstract: The posttransplant lymphoproliferative disease is a severe cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Central Nervous System involvement in EBV-related PTLD is rare, and there is no standard treatment recommendation. We… read more here.
Keywords: ebv related; system involvement; central nervous; lymphoproliferative disease ... See more keywords
Treatment Advances in EBV Related Lymphoproliferative Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.838817
Abstract: Epstein Barr virus (EBV) can affect 90% of the human population. It can invade B lymphocytes, T lymphocytes and natural killer cells of the host and remain in the host for life. The long latency… read more here.
Keywords: cell; ebv related; lymphoproliferative diseases; ebv lpds ... See more keywords